Clinical trial
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD: the TIF vs. Sham Study
NCT01110811 is registered in ClinicalTrials.gov with EndoGastric Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD: the TIF vs. Sham Study
- Lead sponsor
- EndoGastric Solutions
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- December 31, 2018
- Enrollment
- 60 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
gastroesophageal reflux disease, hiatal hernia